The FDA cleared DarioHealth‘s (NSDQ:DRIO) iPhone-compatible blood glucose monitoring system, enabling users to access the company’s Dario app on iPhone 7, 8 and X mobile devices.
The Israel-based company’s product is designed to work with Apple’s latest smartphones, which feature a Lightning connector in place of a standard headphone jack.
Get the full story at our sister site, Drug Delivery Business News.